Heart Monitoring a Must for Breast Cancer Patients on Herceptin
TUESDAY, Aug. 7, 2018 -- The widely used chemotherapy drug trastuzumab (Herceptin) can be life-saving for women with HER2-positive breast cancer, a particularly aggressive form of the disease.
But new research now adds to mounting evidence that the...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Chemotherapy | General Medicine | Heart | HER2 | Herceptin | Women